T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Chesapeake Utilities
CPK
$3.28B
| $204M | 0.03% |
2,384,765
+74,690
| +3% | +$6.94M |
|
402
Franklin Resources
BEN
$17.1B
| $204M | 0.03% |
12,223,993
-3,596,922
| -23% | -$82.6M |
|
403
Home BancShares
HOMB
$6.25B
| $204M | 0.03% |
16,982,135
-87,906
| -0.5% | -$1.52M |
|
404
Papa John's
PZZA
$810M
| $204M | 0.03% |
3,814,132
+541,875
| +17% | +$32.6M |
|
405
EQT Corp
EQT
$33.8B
| $203M | 0.03% |
28,740,906
+637,505
| +2% | +$4.48M |
|
406
Iovance Biotherapeutics
IOVA
$2.96B
| $203M | 0.03% |
6,780,431
+270,575
| +4% | +$7.17M |
|
407
Novanta
NOVT
$6.33B
| $202M | 0.03% |
2,531,968
-52,613
| -2% | -$4.7M |
|
|
PLAN
408
DELISTED
Anaplan, Inc.
PLAN
| $200M | 0.03% |
6,614,900
+810,126
| +14% | +$40.4M |
|
409
IBM
IBM
$221B
| $200M | 0.03% |
1,881,819
+150,772
| +9% | +$19.1M |
|
|
P
410
Everpure Inc
P
$39.1B
| $200M | 0.03% |
16,224,879
+684,531
| +4% | +$11.1M |
|
411
Johnson Controls International
JCI
$92.2B
| $199M | 0.03% |
7,377,412
-4,270,658
| -37% | -$159M |
|
412
Visteon
VC
$2.83B
| $199M | 0.03% |
4,145,042
-263,581
| -6% | -$19.1M |
|
413
Lazard
LAZ
$4.28B
| $199M | 0.03% |
8,437,648
+906,939
| +12% | +$33.6M |
|
414
Southern Copper
SCCO
$162B
| $198M | 0.03% |
7,686,055
+253,044
| +3% | +$8.39M |
|
415
FTI Consulting
FCN
$4.17B
| $198M | 0.03% |
1,655,202
+229,187
| +16% | +$27M |
|
416
Repligen
RGEN
$9.39B
| $198M | 0.03% |
2,048,933
+1,401,743
| +217% | +$135M |
|
417
Corteva
CTVA
$50.4B
| $198M | 0.03% |
8,410,450
-3,239,689
| -28% | -$89.1M |
|
418
Lowe's Companies
LOW
$121B
| $195M | 0.03% |
2,267,924
+105,046
| +5% | +$11.5M |
|
419
Quaker Houghton
KWR
$2.95B
| $194M | 0.03% |
1,534,814
-34,847
| -2% | -$5.65M |
|
420
3M
MMM
$93.4B
| $192M | 0.03% |
1,685,543
-581,163
| -26% | -$76.5M |
|
|
JBTM
421
JBT Marel
JBTM
$6.05B
| $192M | 0.03% |
2,580,417
-20,598
| -0.8% | -$2.06M |
|
422
Exelixis
EXEL
$12.5B
| $191M | 0.03% |
11,093,611
+4,666,620
| +73% | +$85.4M |
|
423
Brown & Brown
BRO
$23.5B
| $191M | 0.03% |
5,272,034
-730,614
| -12% | -$30.9M |
|
424
Pool Corp
POOL
$7.24B
| $191M | 0.03% |
969,918
-238,596
| -20% | -$50.8M |
|
425
Euronet Worldwide
EEFT
$2.68B
| $190M | 0.03% |
2,219,661
+222,547
| +11% | +$29.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.